The chief scientific officer and chief medical officer at Eyevensys discuss the biotech company's pipeline and approach to gene therapy.
Ronald Buggage, MD
Advertisement
Chief medical officer, Eyevensys
Articles by Ronald Buggage, MD
The chief medical officer of Eyevensys discussed the company’s work in developing sustained drug delivery systems.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
Around the Helix: Cell and Gene Therapy Company Updates – October 15, 2025
2
Tr1X's Multiple Sclerosis Cell Therapy TRX319 Cleared for US Trial
3
Guess the Therapy Answer October 16, 2025
4
Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years
5
